
As Fluoride Bans Spread, Who Will Be Hit the Hardest?
Cavities and dental costs are at risk of skyrocketing as a growing number of states consider banning the use of fluoride in public water —and children from low-income households are likely most vulnerable.
In March, Utah became the first state to prohibit adding fluoride to drinking water. A couple months later, Florida followed suit. Several other states are now considering similar bills.
In a recent study published in JAMA Health Forum, researchers projected what would happen if the entire country were to stop adding fluoride to the water supply. The potential impact on both people's oral health and their dental bills was substantial: Tooth decay, the study found, would increase by about 7.5%—representing about 25 million more cavities—and the U.S. would face about $9.8 billion in additional costs over five years, including both what families would have to pay out-of-pocket for dental care and what the government would need to pay for public health insurance.
And those impacts would disproportionately affect children on public insurance plans or without insurance, the researchers found.
Fluoridated water is 'an amazing public health intervention that comes straight from the tap,' says the senior author of the study, Dr. Lisa Simon, an internal medicine physician at Brigham and Women's Hospital, who is also a general dentist.
'Fluoride works for everyone—it benefits adults, it benefits children,' Simon says. 'But the people who derive the most benefit from it are people who have a harder time accessing routine dental care.'
'Unfortunately, in our country, that is more likely to be children and families who are low-income, who rely on public insurance, or who otherwise face challenges in getting to a dentist,' she says.
States' moves to ban the use of fluoride in public drinking water come as the Trump Administration—due in large part to the influence of Robert F. Kennedy Jr., Secretary of the U.S. Department of Health and Human Services (HHS)—has pushed back against the practice. Kennedy has long blasted water fluoridation, claiming it is linked to arthritis, bone cancer, IQ loss, and more, and signaled that HHS will stop recommending it. The Environmental Protection Agency has said that it is studying the potential health risks of fluoride, and the Food and Drug Administration said it is taking steps to remove prescription ingestible fluoride supplements for children from the market.
Some research suggests that fluoride could be associated with lower IQ scores, but only at significantly high levels of exposure—the amount of fluoride that is added to public water, based on federal guidelines, is far lower.
And the majority of public health experts, pediatricians, and dentists insist that water fluoridation is a long-standing practice that is both safe and effective at protecting oral health and fighting cavities and tooth decay.
'It's been touted to be one of the most successful or greatest public health initiatives, right up there with vaccinations,' says Dr. Tomitra Latimer, a pediatrician at Ann & Robert H. Lurie Children's Hospital of Chicago.
U.S. localities started adding fluoride to public water in 1945, and the Centers for Disease Control and Prevention (CDC) has credited the public health initiative for the 'dramatic decline in cavities' in the country in the years since. According to the CDC, drinking fluoridated water reduces cavities by roughly 25% in both children and adults.
Tooth decay, though preventable, is one of the most common childhood diseases. And children of color, children who come from low-income households, children on public insurance plans that limit which providers they can see, and children who live in rural areas and have to travel long distances to access care—all of them are at greater risk of developing cavities, according to Latimer. Children with autism also tend to have a heightened risk of developing cavities because they may struggle with brushing their teeth regularly, she says.
While there are alternative sources of fluoride that people can purchase, the cost may be out of reach for many families, Latimer says. That's why, she says, fluoridated water is so critical: It's an easily accessible tool that can help protect the oral health of children who are most vulnerable to cavities. And for generations, it's flowed straight from the tap.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
RFK Jr's ‘Maha' report found to contain citations to nonexistent studies
Robert F Kennedy Jr's flagship health commission report contains citations to studies that do not exist, according to an investigation by the US publication Notus. The report exposes glaring scientific failures from a health secretary who earlier this week threatened to ban government scientists from publishing in leading medical journals. The 73-page 'Make America healthy again' report – which was commissioned by the Trump administration to examine the causes of chronic illness, and which Kennedy promoted it as 'gold-standard' science backed by more than 500 citations – includes references to seven studies that appear to be entirely invented, and others that the researchers say have been mischaracterized. Related: Key takeaways: RFK Jr's 'Maha' report on chronic disease in children Two supposed studies on ADHD medication advertising simply do not exist in the journals where they are claimed to be published. Virginia Commonwealth University confirmed to Notus that researcher Robert L Findling, listed as an author of one paper, never wrote such an article, while another citation leads only to the Kennedy report itself when searched online. Harold J Farber, a pediatric specialist supposedly behind research on asthma overprescribing, told Notus he never wrote the cited paper and had never worked with the other listed authors. The US Department of Health and Human Services has not immediately responded to a Guardian request for comment. The citation failures come as Kennedy, a noted skeptic of vaccines, criticized medical publishing this week, branding top journals the Lancet, New England Journal of Medicine and Jama as 'corrupt' and alleging they were controlled by pharmaceutical companies. He outlined plans for creating government-run journals instead. Beyond the phantom studies in Kennedy's report, Notus found it systematically misrepresented existing research. Related: RFK's health report omits key facts in painting dark vision for US children For example, one paper was claimed to show that talking therapy was as effective as psychiatric medication, but the statistician Joanne McKenzie said this was impossible, as 'we did not include psychotherapy' in the review. The sleep researcher Mariana G Figueiro also said her study was mischaracterized, with the report incorrectly stating it involved children rather than college students, and citing the wrong journal entirely. The Trump administration asked Kennedy for the report in order to look at chronic illness causes, from pesticides to mobile phone radiation. Kennedy called it a 'milestone' that provides 'evidence-based foundation' for sweeping policy changes. A follow-up 'Make our children healthy again strategy' report is due in August, raising concerns about the scientific credibility underpinning the administration's health agenda.


The Hill
9 hours ago
- The Hill
Trump stokes fear, confusion with pulled emergency abortion guidance
The Trump administration sowed confusion and fear among physicians with its move this past week to rescind Biden-era guidelines to hospitals that provide life-saving abortions. While the move doesn't change the law, doctors and reproductive-rights advocates fear it will have a chilling effect on health care workers in states with abortion bans, ultimately harming pregnant women. Earlier this past week, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) announced they would rescind guidance issued during the Biden administration, which reinforced to hospitals that under the Emergency Medical Treatment and Labor Act (EMTALA,) abortions qualify as stabilizing care in medical emergencies. Emergency rooms in states with abortion bans have been struggling since the 2022 overturning of Roe v. Wade to understand when they can legally provide emergency abortions. After President Trump pulled the Biden-era guidance seeking to clarify that question, emergency room doctors will experience 'more confusion' and 'more fear,' according to health and legal experts who spoke with The Hill. 'Clinicians are scared to provide basic medical care, and this care is clearly in line with medical ethics … medical standards of care, and they're being put in this situation where they can't win,' said Payal Shah, director of research, legal and advocacy at Physicians for Human Rights. Since the Supreme Court overturned Roe v. Wade in 2022, at least 13 states have enacted near-total abortion bans, according to data from the Guttmacher Institute. There are exceptions in these states when continuing a pregnancy poses a threat to the health or life of the mother. However, most of the language in state laws is unclear on how that determination is made, resulting in instances of emergency rooms denying care. Doctors in states like Idaho, Texas and Tennessee have filed lawsuits requesting that lawmakers clarify when an abortion is allowed to save the life of a pregnant person. The doctors and patients involved in the lawsuits argue that state laws do not adequately protect pregnant patients in emergencies. Many of these states have severe punishments for doctors who violate abortion bans, like steep fines and prison time. 'For clinicians, there is actually no safe way to navigate this in this moment, and ultimately, that's how these laws are designed,' Shah said. 'They're designed to cause chaos and confusion. They're often written in ways that don't use medical terminology.' Without clear guidance, pregnant women suffer and sometimes die, as ProPublica has reported. One striking example of this is the 2023 case of Kyleigh Thurman, a Texas woman who was repeatedly denied care for a nonviable pregnancy after days of experiencing bleeding and pain. Health care workers discovered that she had an ectopic pregnancy, which is when a fertilized egg implants and begins to grow outside of the uterus, usually in a fallopian tube. Ectopic pregnancies are never viable and are life-threatening if not treated properly. It wasn't until her OB/GYN 'pleaded to hospital staff that she be given care,' that the hospital administered a shot ending her pregnancy, according to a complaint filed by the Center for Reproductive Rights on behalf of Thurman. The shot came too late, and the ectopic pregnancy ruptured Thurman's right fallopian tube, which was then removed. 'If a patient is actively hemorrhaging or experiencing an ectopic pregnancy which is also life-threatening, doctors need that clear guidance that yes, EMTALA applied,' said Autumn Katz, associate director of U.S. litigation at the Center for Reproductive Rights. A federal investigation into Thurman's case found that the Texas hospital violated EMTALA, according to a recent letter from the CMS. 'I finally got some justice,' Thurman said in a statement. 'I hope this decision will do some good in encouraging hospitals to help women in situations like mine.' Hospitals that violate EMTALA are subject to heavy fines and, in some extreme cases, risk losing a portion of their Medicare and Medicaid hospital funding, according to the National Institutes of Health. Former President Biden leaned on the law to preserve access to emergency abortion across the country, leading to a legal fight with Idaho, which has a strict abortion ban. The Supreme Court last year dismissed the case, declining to rule on the merits of a politically charged case. The rescinding of these guidelines also means hospitals that violate the law will likely not be investigated as often as they were under previous administrations, according to Shah. That lack of punitive risk means that hospitals could be incentivized to deny life-saving care for patients. 'The standard of EMTALA is pretty high,' said Katherine Hempstead, senior policy adviser at Robert Wood Johnson Foundation. 'This kind of takes that layer of reassurance away, and it will make a lot of providers feel very vulnerable.'
Yahoo
11 hours ago
- Yahoo
Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration